Improve Parkinson care via telemedicine
- Trial ID
- NCT06479083
- Official Title
- Interdisciplinary and Intersectoral Telemedicine Evaluation, Coordination and Treatment in the Rhine Main+ Parkinson's Network
- Goal
- Improve Parkinson care via telemedicine
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Johannes Gutenberg University Mainz
- Study Type
- INTERVENTIONAL
- Enrollment
- 1354 participants
- Conditions
- Parkinson Disease
- Interventions
- New Intervention form including, Standard treatment
Summary For Families
The goal is to make specialist Parkinson's care easier to reach and better coordinated across the Rhine-Main region, so symptoms, medications and therapies can be reviewed and adjusted more quickly and consistently. The approach uses an interdisciplinary telemedicine package,video visits with neurologists, structured medication reviews, and coordinated referrals with shared electronic care plans,so teams can optimize levodopa and other treatments, manage side effects, and arrange local therapy without changing how the drugs work. Adults 30 to 85 years old living in Hesse or Rhineland-Palatinate with Parkinson's or atypical Parkinsonism who can give consent are eligible, while people with severe dementia, major psychiatric illness, active addiction, pregnancy, insufficient language skills, or participation in another interventional treatment trial are excluded.
Locations
- Universtity of Saarland, Campus Homburg, Dept. of Neurology, Homburg, Germany
- INSPIRE-PNRM+ Neuroimaging Center (NIC) University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
Frequently Asked Questions
- What is this trial testing?
- This trial is studying New Intervention form including. The goal is to make specialist Parkinson's care easier to reach and better coordinated across the Rhine-Main region, so symptoms, medications and therapies can be reviewed and adjusted more quickly and consistently. The approach uses an interdisciplinary telemedicine package,video visits with neurologists, structured medication reviews, and coordinated referrals with shared electronic care plans,so teams can optimize levodopa and other treatments, manage side effects, and arrange local therapy without changing how the drugs work. Adults 30 to 85 years old living in Hesse or Rhineland-Palatinate with Parkinson's or atypical Parkinsonism who can give consent are eligible, while people with severe dementia, major psychiatric illness, active addiction, pregnancy, insufficient language skills, or participation in another interventional treatment trial are excluded.
- Who can participate?
- Participants must be between 30 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.